Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster-randomised Controlled Phase IV Trial Assessing the Impact of a Vi-Polysaccharide Conjugate Vaccine in Preventing Typhoid Infection in Asante Akim, Ghana (TyVEGHA)

NCT04852185 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT04852185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster-randomised Controlled Phase IV Trial Assessing the Impact of a Vi-Polysaccharide Conjugate Vaccine in Preventing Typhoid Infection in Asante Akim, Ghana (TyVEGHA)
Lead sponsor
International Vaccine Institute
Phase
Phase 4
Overall status
Unknown status
Start date
August 24, 2021
Completion date
December 31, 2024
Enrollment
23,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

typhoid fever